Ceredase
Active Ingredient(s): AlgluceraseFDA Approved: * April 5, 1991
Pharm Company: * GENZYME
Category: Enzymes
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Ceredase Overview
Alglucerase was a biopharmaceutical drug for the treatment of Gaucher's disease. It was a modified form of human β-glucocerebrosidase enzyme, where the non-reducing ends of the oligosaccharide chains have been terminated with mannose residues.[1] Ceredase is the trade name of a citrate buffered solution of alglucerase that was manufactured by Genzyme Corporation from human placental tissue.[1] It is given intravenously in the treatment of Type 1 Gaucher'...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alglucerase
Recent Ceredase Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Alglucerase
- Injection: 10 units/ml, 400unit/5ml, 80 units/ml